- Report
- December 2023
- 100 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- May 2023
- 143 Pages
Global
From €2168EUR$2,250USD£1,865GBP
- Report
- November 2023
- 144 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- October 2023
- 181 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- September 2022
- 104 Pages
Global
From €1927EUR$2,000USD£1,658GBP
Noxafil (posaconazole) is an antifungal medication used to treat a variety of fungal infections. It is used to treat serious fungal infections caused by Aspergillus and Candida species, as well as other fungal infections caused by susceptible organisms. Noxafil is also used to prevent fungal infections in people with weakened immune systems, such as those with HIV/AIDS or cancer. Noxafil is available in both oral and intravenous formulations.
Noxafil is part of the Infectious Diseases Drugs market, which includes medications used to treat a variety of infectious diseases. These drugs are used to treat bacterial, viral, fungal, and parasitic infections. They are used to treat a wide range of infections, from mild to life-threatening.
The Infectious Diseases Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, and AstraZeneca. Other companies in the market include Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Bayer. Show Less Read more
